Michael Pishvaian, MD PhD
Johns Hopkins University · Georgetown Lombardi Comprehensive Cancer Center · Georgetown University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Michael Pishvaian, MD PhD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:19 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07605702 · The Canopy Cancer Collective Clinical Registry ProtocolCanopy Cancer Collective, LLC · not yet recruiting · Gastrointestinal Neoplasms, Pancreatic Cancer, Colorectal Cancer · study chair
- Ph1/Ph2NCT03376659 · Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic AdenocarcinomaGeorgetown University · terminated · Metastatic Colorectal Cancer, Colorectal Adenocarcinoma, Pancreatic Adenocarcinoma · study chair
- Ph2NCT02967770 · Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic CancerGeorgetown University · withdrawn · Metastatic Pancreatic Cancer · study chair
- Ph2NCT02249949 · Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by SurgeryAlliance for Clinical Trials in Oncology · completed · Liposarcoma · study chair
- Ph2NCT02242409 · Study of Gemcitabine and Abraxane for Pancreas CancerGeorgetown University · terminated · Pancreatic Cancer · principal investigator
- Ph1NCT01522989 · PD-0332991, 5-FU, and Oxaliplatin for Advanced Solid Tumor MalignanciesGeorgetown University · unknown · Advanced Solid Tumor Malignancies · principal investigator
- Ph1/Ph2NCT01504477 · Panitumumab and Bortezomib for Patients With Advanced Colorectal CancerGeorgetown University · terminated · Colorectal Cancer · principal investigator
- Ph1NCT01504490 · Phase I Study of CS-7017 and BexaroteneGeorgetown University · terminated · Solid Tumors, Lymphoma, Multiple Myeloma · principal investigator
- Ph1NCT01497626 · Lapatinib and Bortezomib in Patients With Advanced MalignanciesGeorgetown University · terminated · Advanced Solid Tumors · principal investigator
- Ph1/Ph2NCT01489865 · ABT-888 With Modified FOLFOX6 in Patients With Metastatic Pancreatic CancerGeorgetown University · completed · Metastatic Pancreatic Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:19 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in multiple myeloma.